Asset Details
Do you wish to reserve the book?
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
Do you wish to request the book?
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
2019
Overview
Patients with atrial fibrillation and stable coronary artery disease were assigned to receive either rivaroxaban monotherapy or combination therapy with rivaroxaban plus a single antiplatelet agent. At 2 years, monotherapy was noninferior to combination therapy with respect to ischemic events and superior with respect to major bleeding.
Publisher
Massachusetts Medical Society
Subject
/ Aged
/ Angina
/ Atrial Fibrillation - complications
/ Atrial Fibrillation - drug therapy
/ Atrial Fibrillation - mortality
/ Coronary Disease - complications
/ Drug Therapy, Combination - adverse effects
/ Embolism
/ Factor Xa Inhibitors - adverse effects
/ Factor Xa Inhibitors - therapeutic use
/ Female
/ Humans
/ Male
/ Percutaneous Coronary Intervention
/ Platelet Aggregation Inhibitors - adverse effects
/ Platelet Aggregation Inhibitors - therapeutic use
/ Purinergic P2Y Receptor Antagonists - therapeutic use
/ Rivaroxaban - adverse effects
/ Rivaroxaban - therapeutic use
/ Safety
/ Stroke
